Clinical outcomes of a Phase II, multi-institutional Cesium-131 permanent prostate brachytherapy trial
To access this article, please choose from the options below
This work was supported by Isoray Medical, manufacturers of the source type used in the study.
PII: S1538-4721(07)00038-4
doi:10.1016/j.brachy.2007.02.006
© 2007 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
